Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
作者： Mohammad Hadi Eskandari , Ali Niazi , Alireza Afsharifar , Daria Rutkowska , Nahid Rezaei
DOI: 10.1016/J.BTRE.2021.E00605
关键词:
摘要: … system include high costs of production, purification, and … plant expression system is a suitable alternative with high potential in the production of recombinant vaccines and antibodies …
sci-hub.st 参考文章(207)
Paul Pumpens, Elmars Grens, HBV Core Particles as a Carrier for B Cell/T Cell Epitopes Intervirology. ,vol. 44, pp. 98- 114 ,(2001) , 10.1159/000050037
Rob Noad, Polly Roy, None, Virus-like particles as immunogens Trends in Microbiology. ,vol. 11, pp. 438- 444 ,(2003) , 10.1016/S0966-842X(03)00208-7
Y. Thanavala, M. Mahoney, S. Pal, A. Scott, L. Richter, N. Natarajan, P. Goodwin, C. J. Arntzen, H. S. Mason, Immunogenicity in humans of an edible vaccine for hepatitis B. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 3378- 3382 ,(2005) , 10.1073/PNAS.0409899102
Agnes Le Bon, Nathalie Etchart, Cornelia Rossmann, Miranda Ashton, Sam Hou, Dirk Gewert, Persephone Borrow, David F Tough, Cross-priming of CD8 + T cells stimulated by virus-induced type I interferon Nature Immunology. ,vol. 4, pp. 1009- 1015 ,(2003) , 10.1038/NI978
Maren Vogel, Manuel Diez, Jochen Eisfeld, Michael Nassal, In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): Rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs FEBS Letters. ,vol. 579, pp. 5211- 5216 ,(2005) , 10.1016/J.FEBSLET.2005.08.044
Marina De Filette, Wouter Martens, Anouk Smet, Michael Schotsaert, Ashley Birkett, Patricia Londoño-Arcila, Walter Fiers, Xavier Saelens, Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies Vaccine. ,vol. 26, pp. 6503- 6507 ,(2008) , 10.1016/J.VACCINE.2008.09.038
Sudhir Sahdev, Sunil K. Khattar, Kulvinder Singh Saini, Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Molecular and Cellular Biochemistry. ,vol. 307, pp. 249- 264 ,(2007) , 10.1007/S11010-007-9603-6
Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen, Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice Vaccine. ,vol. 31, pp. 3281- 3287 ,(2013) , 10.1016/J.VACCINE.2013.05.019
Gregory M. Pastores, Milan Petakov, Pilar Giraldo, Hanna Rosenbaum, Jeffrey Szer, Patrick B. Deegan, Dominick J. Amato, Eugen Mengel, Ee Shien Tan, Raul Chertkoff, Einat Brill-Almon, Ari Zimran, A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase Blood Cells, Molecules, and Diseases. ,vol. 53, pp. 253- 260 ,(2014) , 10.1016/J.BCMD.2014.05.004
Qinjian Zhao, Michael J. Allen, Yang Wang, Bei Wang, Ning Wang, Li Shi, Robert D. Sitrin, Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles Nanomedicine: Nanotechnology, Biology and Medicine. ,vol. 8, pp. 1182- 1189 ,(2012) , 10.1016/J.NANO.2012.01.007